MAPT and tauopathy: A number of reports show the ability of ROCK inhibitors to reduce the levels of phosphorylated tau and oligomeric tau protein (Hamano et al., 2020; Saray et al., 2021), pointing to the possible preventive therapeutic potential of fasudil for the treatment of tauopathies.